aluates Reports

$ 0.0

Automative

Global Dermatological OTC Drugs Market Research Report 2024

Published Date: May 2024

Report Code: QYRE-Auto-4P11594

Global Dermatological OTC Drugs Market Research Report 2022

BUY CHAPTERS

Global Dermatological OTC Drugs Market Research Report 2024

Code: QYRE-Auto-4P11594

Report

May 2024

Pages:87

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Perrigo Company plc

Bausch Health Companies Inc.

Dr. Reddy’s Laboratories

Johnson and Johnson

Bayer

GlaxoSmithKline PLC

Viatris

LEO Pharma A/S

Acella Pharmaceuticals, LLC

Teva Pharmaceutical Industries Ltd

Galderma

Dermatological OTC Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Dermatological OTC Drugs Market

The global Dermatological OTC Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Dermatological OTC Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermatological OTC Drugs.

Report Scope

The Dermatological OTC Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dermatological OTC Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Dermatological OTC Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Dermatological OTC Drugs Market Report

Report Metric	Details
Report Name	Dermatological OTC Drugs Market
CAGR	5%
Segment by Type	Acne Medications Dermatitis Drugs Fungal Infection Drugs
Segment by Application	Online Distribution Offline Distribution
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Perrigo Company plc, Bausch Health Companies Inc., Dr. Reddy's Laboratories, Johnson and Johnson, Bayer AG, GlaxoSmithKline plc., Viatris Inc, LEO Pharma A/S, Acella Pharmaceuticals, LLC, Teva Pharmaceutical Industries Ltd., Galderma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dermatological OTC Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Dermatological OTC Drugs Market report?

Ans: The main players in the Dermatological OTC Drugs Market are Perrigo Company plc, Bausch Health Companies Inc., Dr. Reddy's Laboratories, Johnson and Johnson, Bayer AG, GlaxoSmithKline plc., Viatris Inc, LEO Pharma A/S, Acella Pharmaceuticals, LLC, Teva Pharmaceutical Industries Ltd., Galderma

What are the Application segmentation covered in the Dermatological OTC Drugs Market report?

Ans: The Applications covered in the Dermatological OTC Drugs Market report are Online Distribution, Offline Distribution

What are the Type segmentation covered in the Dermatological OTC Drugs Market report?

Ans: The Types covered in the Dermatological OTC Drugs Market report are Acne Medications, Dermatitis Drugs, Fungal Infection Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Dermatological OTC Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Acne Medications

1.2.3 Dermatitis Drugs

1.2.4 Fungal Infection Drugs

1.3 Market by Application

1.3.1 Global Dermatological OTC Drugs Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Online Distribution

1.3.3 Offline Distribution

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Dermatological OTC Drugs Market Perspective (2019-2030)

2.2 Dermatological OTC Drugs Growth Trends by Region

2.2.1 Global Dermatological OTC Drugs Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Dermatological OTC Drugs Historic Market Size by Region (2019-2024)

2.2.3 Dermatological OTC Drugs Forecasted Market Size by Region (2025-2030)

2.3 Dermatological OTC Drugs Market Dynamics

2.3.1 Dermatological OTC Drugs Industry Trends

2.3.2 Dermatological OTC Drugs Market Drivers

2.3.3 Dermatological OTC Drugs Market Challenges

2.3.4 Dermatological OTC Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Dermatological OTC Drugs Players by Revenue

3.1.1 Global Top Dermatological OTC Drugs Players by Revenue (2019-2024)

3.1.2 Global Dermatological OTC Drugs Revenue Market Share by Players (2019-2024)

3.2 Global Dermatological OTC Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Dermatological OTC Drugs Revenue

3.4 Global Dermatological OTC Drugs Market Concentration Ratio

3.4.1 Global Dermatological OTC Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Dermatological OTC Drugs Revenue in 2023

3.5 Dermatological OTC Drugs Key Players Head office and Area Served

3.6 Key Players Dermatological OTC Drugs Product Solution and Service

3.7 Date of Enter into Dermatological OTC Drugs Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Dermatological OTC Drugs Breakdown Data by Type

4.1 Global Dermatological OTC Drugs Historic Market Size by Type (2019-2024)

4.2 Global Dermatological OTC Drugs Forecasted Market Size by Type (2025-2030)

5 Dermatological OTC Drugs Breakdown Data by Application

5.1 Global Dermatological OTC Drugs Historic Market Size by Application (2019-2024)

5.2 Global Dermatological OTC Drugs Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Dermatological OTC Drugs Market Size (2019-2030)

6.2 North America Dermatological OTC Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Dermatological OTC Drugs Market Size by Country (2019-2024)

6.4 North America Dermatological OTC Drugs Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Dermatological OTC Drugs Market Size (2019-2030)

7.2 Europe Dermatological OTC Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Dermatological OTC Drugs Market Size by Country (2019-2024)

7.4 Europe Dermatological OTC Drugs Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Dermatological OTC Drugs Market Size (2019-2030)

8.2 Asia-Pacific Dermatological OTC Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Dermatological OTC Drugs Market Size by Region (2019-2024)

8.4 Asia-Pacific Dermatological OTC Drugs Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Dermatological OTC Drugs Market Size (2019-2030)

9.2 Latin America Dermatological OTC Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Dermatological OTC Drugs Market Size by Country (2019-2024)

9.4 Latin America Dermatological OTC Drugs Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Dermatological OTC Drugs Market Size (2019-2030)

10.2 Middle East & Africa Dermatological OTC Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Dermatological OTC Drugs Market Size by Country (2019-2024)

10.4 Middle East & Africa Dermatological OTC Drugs Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Perrigo Company plc

11.1.1 Perrigo Company plc Company Detail

11.1.2 Perrigo Company plc Business Overview

11.1.3 Perrigo Company plc Dermatological OTC Drugs Introduction

11.1.4 Perrigo Company plc Revenue in Dermatological OTC Drugs Business (2019-2024)

11.1.5 Perrigo Company plc Recent Development

11.2 Bausch Health Companies Inc.

11.2.1 Bausch Health Companies Inc. Company Detail

11.2.2 Bausch Health Companies Inc. Business Overview

11.2.3 Bausch Health Companies Inc. Dermatological OTC Drugs Introduction

11.2.4 Bausch Health Companies Inc. Revenue in Dermatological OTC Drugs Business (2019-2024)

11.2.5 Bausch Health Companies Inc. Recent Development

11.3 Dr. Reddy's Laboratories

11.3.1 Dr. Reddy's Laboratories Company Detail

11.3.2 Dr. Reddy's Laboratories Business Overview

11.3.3 Dr. Reddy's Laboratories Dermatological OTC Drugs Introduction

11.3.4 Dr. Reddy's Laboratories Revenue in Dermatological OTC Drugs Business (2019-2024)

11.3.5 Dr. Reddy's Laboratories Recent Development

11.4 Johnson and Johnson

11.4.1 Johnson and Johnson Company Detail

11.4.2 Johnson and Johnson Business Overview

11.4.3 Johnson and Johnson Dermatological OTC Drugs Introduction

11.4.4 Johnson and Johnson Revenue in Dermatological OTC Drugs Business (2019-2024)

11.4.5 Johnson and Johnson Recent Development

11.5 Bayer AG

11.5.1 Bayer AG Company Detail

11.5.2 Bayer AG Business Overview

11.5.3 Bayer AG Dermatological OTC Drugs Introduction

11.5.4 Bayer AG Revenue in Dermatological OTC Drugs Business (2019-2024)

11.5.5 Bayer AG Recent Development

11.6 GlaxoSmithKline plc.

11.6.1 GlaxoSmithKline plc. Company Detail

11.6.2 GlaxoSmithKline plc. Business Overview

11.6.3 GlaxoSmithKline plc. Dermatological OTC Drugs Introduction

11.6.4 GlaxoSmithKline plc. Revenue in Dermatological OTC Drugs Business (2019-2024)

11.6.5 GlaxoSmithKline plc. Recent Development

11.7 Viatris Inc

11.7.1 Viatris Inc Company Detail

11.7.2 Viatris Inc Business Overview

11.7.3 Viatris Inc Dermatological OTC Drugs Introduction

11.7.4 Viatris Inc Revenue in Dermatological OTC Drugs Business (2019-2024)

11.7.5 Viatris Inc Recent Development

11.8 LEO Pharma A/S

11.8.1 LEO Pharma A/S Company Detail

11.8.2 LEO Pharma A/S Business Overview

11.8.3 LEO Pharma A/S Dermatological OTC Drugs Introduction

11.8.4 LEO Pharma A/S Revenue in Dermatological OTC Drugs Business (2019-2024)

11.8.5 LEO Pharma A/S Recent Development

11.9 Acella Pharmaceuticals, LLC

11.9.1 Acella Pharmaceuticals, LLC Company Detail

11.9.2 Acella Pharmaceuticals, LLC Business Overview

11.9.3 Acella Pharmaceuticals, LLC Dermatological OTC Drugs Introduction

11.9.4 Acella Pharmaceuticals, LLC Revenue in Dermatological OTC Drugs Business (2019-2024)

11.9.5 Acella Pharmaceuticals, LLC Recent Development

11.10 Teva Pharmaceutical Industries Ltd.

11.10.1 Teva Pharmaceutical Industries Ltd. Company Detail

11.10.2 Teva Pharmaceutical Industries Ltd. Business Overview

11.10.3 Teva Pharmaceutical Industries Ltd. Dermatological OTC Drugs Introduction

11.10.4 Teva Pharmaceutical Industries Ltd. Revenue in Dermatological OTC Drugs Business (2019-2024)

11.10.5 Teva Pharmaceutical Industries Ltd. Recent Development

11.11 Galderma

11.11.1 Galderma Company Detail

11.11.2 Galderma Business Overview

11.11.3 Galderma Dermatological OTC Drugs Introduction

11.11.4 Galderma Revenue in Dermatological OTC Drugs Business (2019-2024)

11.11.5 Galderma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Perrigo Company plc

Bausch Health Companies Inc.

Dr. Reddy’s Laboratories

Johnson and Johnson

Bayer

GlaxoSmithKline PLC

Viatris

LEO Pharma A/S

Acella Pharmaceuticals, LLC

Teva Pharmaceutical Industries Ltd

Galderma

List of Tables

Table 1. Global Dermatological OTC Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Acne Medications

Table 3. Key Players of Dermatitis Drugs

Table 4. Key Players of Fungal Infection Drugs

Table 5. Global Dermatological OTC Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Dermatological OTC Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Dermatological OTC Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Dermatological OTC Drugs Market Share by Region (2019-2024)

Table 9. Global Dermatological OTC Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Dermatological OTC Drugs Market Share by Region (2025-2030)

Table 11. Dermatological OTC Drugs Market Trends

Table 12. Dermatological OTC Drugs Market Drivers

Table 13. Dermatological OTC Drugs Market Challenges

Table 14. Dermatological OTC Drugs Market Restraints

Table 15. Global Dermatological OTC Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Dermatological OTC Drugs Market Share by Players (2019-2024)

Table 17. Global Top Dermatological OTC Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatological OTC Drugs as of 2023)

Table 18. Ranking of Global Top Dermatological OTC Drugs Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Dermatological OTC Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Dermatological OTC Drugs Product Solution and Service

Table 22. Date of Enter into Dermatological OTC Drugs Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Dermatological OTC Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Dermatological OTC Drugs Revenue Market Share by Type (2019-2024)

Table 26. Global Dermatological OTC Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Dermatological OTC Drugs Revenue Market Share by Type (2025-2030)

Table 28. Global Dermatological OTC Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Dermatological OTC Drugs Revenue Market Share by Application (2019-2024)

Table 30. Global Dermatological OTC Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Dermatological OTC Drugs Revenue Market Share by Application (2025-2030)

Table 32. North America Dermatological OTC Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Dermatological OTC Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Dermatological OTC Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Dermatological OTC Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Dermatological OTC Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Dermatological OTC Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Dermatological OTC Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Dermatological OTC Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Dermatological OTC Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Dermatological OTC Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Dermatological OTC Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Dermatological OTC Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Dermatological OTC Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Dermatological OTC Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Dermatological OTC Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 47. Perrigo Company plc Company Detail

Table 48. Perrigo Company plc Business Overview

Table 49. Perrigo Company plc Dermatological OTC Drugs Product

Table 50. Perrigo Company plc Revenue in Dermatological OTC Drugs Business (2019-2024) & (US$ Million)

Table 51. Perrigo Company plc Recent Development

Table 52. Bausch Health Companies Inc. Company Detail

Table 53. Bausch Health Companies Inc. Business Overview

Table 54. Bausch Health Companies Inc. Dermatological OTC Drugs Product

Table 55. Bausch Health Companies Inc. Revenue in Dermatological OTC Drugs Business (2019-2024) & (US$ Million)

Table 56. Bausch Health Companies Inc. Recent Development

Table 57. Dr. Reddy's Laboratories Company Detail

Table 58. Dr. Reddy's Laboratories Business Overview

Table 59. Dr. Reddy's Laboratories Dermatological OTC Drugs Product

Table 60. Dr. Reddy's Laboratories Revenue in Dermatological OTC Drugs Business (2019-2024) & (US$ Million)

Table 61. Dr. Reddy's Laboratories Recent Development

Table 62. Johnson and Johnson Company Detail

Table 63. Johnson and Johnson Business Overview

Table 64. Johnson and Johnson Dermatological OTC Drugs Product

Table 65. Johnson and Johnson Revenue in Dermatological OTC Drugs Business (2019-2024) & (US$ Million)

Table 66. Johnson and Johnson Recent Development

Table 67. Bayer AG Company Detail

Table 68. Bayer AG Business Overview

Table 69. Bayer AG Dermatological OTC Drugs Product

Table 70. Bayer AG Revenue in Dermatological OTC Drugs Business (2019-2024) & (US$ Million)

Table 71. Bayer AG Recent Development

Table 72. GlaxoSmithKline plc. Company Detail

Table 73. GlaxoSmithKline plc. Business Overview

Table 74. GlaxoSmithKline plc. Dermatological OTC Drugs Product

Table 75. GlaxoSmithKline plc. Revenue in Dermatological OTC Drugs Business (2019-2024) & (US$ Million)

Table 76. GlaxoSmithKline plc. Recent Development

Table 77. Viatris Inc Company Detail

Table 78. Viatris Inc Business Overview

Table 79. Viatris Inc Dermatological OTC Drugs Product

Table 80. Viatris Inc Revenue in Dermatological OTC Drugs Business (2019-2024) & (US$ Million)

Table 81. Viatris Inc Recent Development

Table 82. LEO Pharma A/S Company Detail

Table 83. LEO Pharma A/S Business Overview

Table 84. LEO Pharma A/S Dermatological OTC Drugs Product

Table 85. LEO Pharma A/S Revenue in Dermatological OTC Drugs Business (2019-2024) & (US$ Million)

Table 86. LEO Pharma A/S Recent Development

Table 87. Acella Pharmaceuticals, LLC Company Detail

Table 88. Acella Pharmaceuticals, LLC Business Overview

Table 89. Acella Pharmaceuticals, LLC Dermatological OTC Drugs Product

Table 90. Acella Pharmaceuticals, LLC Revenue in Dermatological OTC Drugs Business (2019-2024) & (US$ Million)

Table 91. Acella Pharmaceuticals, LLC Recent Development

Table 92. Teva Pharmaceutical Industries Ltd. Company Detail

Table 93. Teva Pharmaceutical Industries Ltd. Business Overview

Table 94. Teva Pharmaceutical Industries Ltd. Dermatological OTC Drugs Product

Table 95. Teva Pharmaceutical Industries Ltd. Revenue in Dermatological OTC Drugs Business (2019-2024) & (US$ Million)

Table 96. Teva Pharmaceutical Industries Ltd. Recent Development

Table 97. Galderma Company Detail

Table 98. Galderma Business Overview

Table 99. Galderma Dermatological OTC Drugs Product

Table 100. Galderma Revenue in Dermatological OTC Drugs Business (2019-2024) & (US$ Million)

Table 101. Galderma Recent Development

Table 102. Research Programs/Design for This Report

Table 103. Key Data Information from Secondary Sources

Table 104. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Dermatological OTC Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Dermatological OTC Drugs Market Share by Type: 2023 VS 2030

Figure 3. Acne Medications Features

Figure 4. Dermatitis Drugs Features

Figure 5. Fungal Infection Drugs Features

Figure 6. Global Dermatological OTC Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Dermatological OTC Drugs Market Share by Application: 2023 VS 2030

Figure 8. Online Distribution Case Studies

Figure 9. Offline Distribution Case Studies

Figure 10. Dermatological OTC Drugs Report Years Considered

Figure 11. Global Dermatological OTC Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Dermatological OTC Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Dermatological OTC Drugs Market Share by Region: 2023 VS 2030

Figure 14. Global Dermatological OTC Drugs Market Share by Players in 2023

Figure 15. Global Top Dermatological OTC Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatological OTC Drugs as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Dermatological OTC Drugs Revenue in 2023

Figure 17. North America Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Dermatological OTC Drugs Market Share by Country (2019-2030)

Figure 19. United States Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Dermatological OTC Drugs Market Share by Country (2019-2030)

Figure 23. Germany Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Dermatological OTC Drugs Market Share by Region (2019-2030)

Figure 31. China Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Dermatological OTC Drugs Market Share by Country (2019-2030)

Figure 39. Mexico Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Dermatological OTC Drugs Market Share by Country (2019-2030)

Figure 43. Turkey Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia Dermatological OTC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Perrigo Company plc Revenue Growth Rate in Dermatological OTC Drugs Business (2019-2024)

Figure 46. Bausch Health Companies Inc. Revenue Growth Rate in Dermatological OTC Drugs Business (2019-2024)

Figure 47. Dr. Reddy's Laboratories Revenue Growth Rate in Dermatological OTC Drugs Business (2019-2024)

Figure 48. Johnson and Johnson Revenue Growth Rate in Dermatological OTC Drugs Business (2019-2024)

Figure 49. Bayer AG Revenue Growth Rate in Dermatological OTC Drugs Business (2019-2024)

Figure 50. GlaxoSmithKline plc. Revenue Growth Rate in Dermatological OTC Drugs Business (2019-2024)

Figure 51. Viatris Inc Revenue Growth Rate in Dermatological OTC Drugs Business (2019-2024)

Figure 52. LEO Pharma A/S Revenue Growth Rate in Dermatological OTC Drugs Business (2019-2024)

Figure 53. Acella Pharmaceuticals, LLC Revenue Growth Rate in Dermatological OTC Drugs Business (2019-2024)

Figure 54. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Dermatological OTC Drugs Business (2019-2024)

Figure 55. Galderma Revenue Growth Rate in Dermatological OTC Drugs Business (2019-2024)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Prescription Dermatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Dermatology Diagnostic Tools Market Research Report 2025

Global OTC Scar Treatment Market Research Report 2025

Global OTC Scar Treatment Products Market Research Report 2025

Global Dermatomycoses Drug Market Research Report 2025

OTC Allergy Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Non melanoma Skin Cancer Drugs Market Research Report 2024

Global OTC Pain Medicines Market Research Report 2024

Global Livestock Dermatology Drugs Market Research Report 2025

Global Psoriasis Treatment Drugs Market Research Report 2025

Psoriasis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Dermatitis Herpetiformis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

OTC Cat Medicines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Alopecia Treatment Market Research Report 2024

Over the Counter Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Skin Pigmentation Disorder Treatment Market Research Report 2024

Global Onychomycosis Treatment Technique Market Research Report 2024

Scar Removal Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Canine and Feline Dermatology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions